[Treatment of fulminant hepatitis with coma by exchange transfusion. Study of 9 patients, including 1 with neurological sequelae in the cortical functions (author's transl)].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000377:Agnosia / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004569:Electroencephalography; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D006506:Hepatitis A / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013064:Speech Disorders / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D004295:Dihydroxyphenylalanine
Le traitement des hépatites fulminantes avec coma par exsanguino-transfusions. Etude de 9 patients dont 1 a présenté des séquelles neurologiques au niveau des fonctions corticales